Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tenaya Therapeutics Inc (TNYA)

Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tenaya Therapeutics Inc 171 OYSTER POINT BOULEVARD SUITE 500 SOUTH SAN FRANCISCO CA 94080 USA

www.tenayatherapeutics.com Employees: 97 P: 650-825-6990

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Tenaya Therapeutics Inc. is a biotechnology company. It discovers, develop and deliver curative therapies which address the underlying causes of heart disease. The company's product platform consist Gene Therapy, Cellular Regeneration and Precision Medicine. Tenaya Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 101,407
Enterprise Value, $K 97,087
Shares Outstanding, K 163,745
Float, K 84,083
% Float 51.35%
Short Interest, K 24,946
Short Float 15.24%
Days to Cover 6.15
Short Volume Ratio 0.53
% of Insider Shareholders 48.65%
% of Institutional Shareholders 90.54%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -111,130 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -20,280 K
EBIT, $ -97,210 K
EBITDA, $ -88,930 K

Growth:

1-Year Return -45.19%
3-Year Return -77.88%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.12 on 11/10/25
Next Earnings Date 03/09/26 [--]
Earnings Per Share ttm -0.78
EPS Growth vs. Prev Qtr 14.29%
EPS Growth vs. Prev Year 60.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TNYA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -95.46%
Return-on-Assets % -76.79%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.24
Book Value/Share 0.51
Interest Coverage -2.80
60-Month Beta 3.18
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar